(15)malignant lymphoma

Upload: surya-budikusuma

Post on 04-Jun-2018

217 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/13/2019 (15)Malignant Lymphoma

    1/29

    MALIGNANT LYMPHOMA

    NI PUTU EKAWATI

  • 8/13/2019 (15)Malignant Lymphoma

    2/29

    Lnn Distribution

  • 8/13/2019 (15)Malignant Lymphoma

    3/29

    Normal Histology

  • 8/13/2019 (15)Malignant Lymphoma

    4/29

    General Disorders

    Reactive

    Proliferations of

    White cells andNodes

    Acute Nonspesific

    Lympadenitis

    Chronic NonspesificLympadenitis

    Spesific

    lympadenitis

    NeoplasticProliferations ofWhite Cells Lymphoid neoplasm

    Myeloid NeoplasmAML, MDS, MPD

    Langerhans cell

    Neoplasm

  • 8/13/2019 (15)Malignant Lymphoma

    5/29

    Malignant Lymphoma

    Malignant counterpart of normal

    lymphocytes

  • 8/13/2019 (15)Malignant Lymphoma

    6/29

    Lymphoma Vs Leukemia

    Leukemia : lymphoid neoplasm presentwith widespread involv. of the BM, usuallyaccompanied by the presences of large

    numbers of tumor cells in peripheral blood Lymphoma : proliferations arising as

    discrete tissue masses.

  • 8/13/2019 (15)Malignant Lymphoma

    7/29

    Etiological and Pathogenetic factors

    Chr translocation and oncogenes

    Inherited genetic factor

    Viruses

    HTLV 1, EBV

    Enviromental agents

    H pylori

    Gluten sensitive enteropathy

    Iatrogenic

    Radiotherapy

    Chemotherapy

  • 8/13/2019 (15)Malignant Lymphoma

    8/29

    WHO Classification : Reflection of the

    complexity of lymphoid differentiation

    Tumor biology

    Histomorphology

    Immunophenotype

    Molecular genetics

    Purpose

    Ordering Prognostication

    Treatment categories

  • 8/13/2019 (15)Malignant Lymphoma

    9/29

    WHO Classification

    Lineage differentiation (B,T,NK)

    Stage of maturation

    Precursor B/T cell

    Mature B/T cell

    Localization (nodal Vs MALT, skin, spleen)

    Molecular (Bcl1, Bcl2, Myc, ALK etc)

  • 8/13/2019 (15)Malignant Lymphoma

    10/29

    WHO Classification

    B Cell neoplasm Precursor B cell neoplasm

    Mature B cell neoplasm CLL/SLL

    Prolymphocytic leukemia

    Lymphoplasmacytic lymphoma

    Spleenic marginal zone lymphoma Hairy cell leukemia

    Plasma cell myeloma

    Extraosseus plasmacytoma

    Marginal zone leukemia extranodal (MALT)

    Marginal zone leukemia Nodal

    Follicular lymphoma

    Mantle cell lymphoma

    Diffuse large B cell lymphoma(var mediastinal)

    Burkit lymphoma

    Intravascular and primary effusion lymphoma

  • 8/13/2019 (15)Malignant Lymphoma

    11/29

  • 8/13/2019 (15)Malignant Lymphoma

    12/29

  • 8/13/2019 (15)Malignant Lymphoma

    13/29

  • 8/13/2019 (15)Malignant Lymphoma

    14/29

    WHO Classification

    T Cell and NK Neoplasm

    Precursor T/NK cell neoplasm

    Mature T/NK cell neoplasm Leucemic / disseminated

    T-cell prolymphocytic leukemia

    Cutaneus Mycosis funguides/Sezary syndrome

    Primary cutaneus anaplastic large cell lymphoma

    Other extranodal NK/T cell lymphoma, nasal type Hepatosleenic T-cell lymphoma

    NodalAngioimunoblastic lymphoma

    Anaplastic large cell lymphoma

  • 8/13/2019 (15)Malignant Lymphoma

    15/29

  • 8/13/2019 (15)Malignant Lymphoma

    16/29

    Frequent feature of mature T/NK cell

    lymphoma

    Broad cytologic spectrum

    Disease definition is heavily dependentupon clinical features, not morphology

    Infrequent lymph node involvement

    Frequent spread to other extranodal sites

    Cytotoxic T cell or NK cell phenotype

    Frequent apoptosis and/or necrosis

  • 8/13/2019 (15)Malignant Lymphoma

    17/29

    WHO Classification

    Hodgkin lymphoma

    Nodular lymphocyte predominant HD

    Classical HD

    Nodular sclerosis HD

    Lymphocyte rich classical HD

    Mixed cellularity classical HD

    Lymphocyte depleted classical HD

  • 8/13/2019 (15)Malignant Lymphoma

    18/29

    HODGKIN LYMPHOMA

    Clinically, spread in contiguous fashion

    Histologically:

    Reed-sternberg cells

    Inflammatory cells

    RSC derived from B cell of germinal centre

    Response to specific types of therapy

  • 8/13/2019 (15)Malignant Lymphoma

    19/29

    Clinical differences HL x NHL

    HL

    Localized to a single

    axial group of nodes

    Spread by contiguity Mesenteric &

    Waldeyer ring rarely

    involved

    Extranodal uncommon

    NHL

    Multiple pheriperal

    nodes

    Non contiguous Commonly involved

    Common

  • 8/13/2019 (15)Malignant Lymphoma

    20/29

  • 8/13/2019 (15)Malignant Lymphoma

    21/29

  • 8/13/2019 (15)Malignant Lymphoma

    22/29

    Ann Arbor staging classification

    Stage I : involvement of single lymph noderegion or lymphoid structure

    Stage II : involvement of two or more lymph

    nodes regions on the same side of diaphragm Stage III : involvement of lymph node regions or

    structures on both sides of diaphragm

    Stage IV : involvement of extranodal site(s)

  • 8/13/2019 (15)Malignant Lymphoma

    23/29

    Grouping Lymphoma by

    Clinical Behavior

    Lymphoma that are indolent (slow

    growing) but usually incurable

    CLL/SLL

    Follicular lymphoma

    MALT lymphoma

  • 8/13/2019 (15)Malignant Lymphoma

    24/29

    Lymphoma that are fairly aggressive if

    untreated but may be cured with

    appropriate therapy

    Hodgkin disease

    Follicular lymphoma, large cell type

    Diffuse large B cell lymphoma

  • 8/13/2019 (15)Malignant Lymphoma

    25/29

  • 8/13/2019 (15)Malignant Lymphoma

    26/29

    CD 20 (IHK)

  • 8/13/2019 (15)Malignant Lymphoma

    27/29

    MF

  • 8/13/2019 (15)Malignant Lymphoma

    28/29

    MF

  • 8/13/2019 (15)Malignant Lymphoma

    29/29